mrd to support treatment planning in a young, high-risk all patient
Published 3 years ago • 212 plays • Length 9:20Download video MP4
Download video MP3
Similar videos
-
4:19
mrd to assess response and inform transplant decision in a relapsed all patient
-
7:24
mrd helps predict outcomes and informs transplant decision for an all patient
-
6:32
mrd helps predict outcomes and informs transplant decision for an all patient
-
5:42
initiating consolidation prior to transplant based on mrd positivity in acute lymphoblastic leukemia
-
9:35
mrd helps predict outcomes and informs maintenance treatment for a myeloma patient
-
5:17
approaches to and the use of mrd in all
-
1:33:36
antibody therapy in all: how and why to integrate antibody-based treatment into patient management
-
1:56:56
redefining patient care in acute lymphoblastic leukemia
-
3:27
transplant in all after car t-cells & the role of mrd
-
1:40
identifying patients at different risk of relapse in childhood acute lymphoblastic leukemia (all)
-
2:34
mrd is the best predictor for treatment success in aml
-
2:44
promising results for blinatumomab in younger b-all at first relapsed
-
20:56
diagnosis and treatment of newly diagnosed all
-
1:32:31
management of adult all: prasanth ganesan
-
5:51
establishing mrd’s role in all management
-
2:06
identifying relapse in b-all patients treated with tisagenlecleucel using mrd
-
4:07
acute lymphoblastic leukaemia (all): practical stuff
-
1:41:49
current treatment & research in adult acute lymphoblastic leukaemia (all)